Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 USD | -2.58% | +14.48% | -19.24% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.24% | 762M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac Patent Invalidated by German Court After BioNTech Nullity Action